文献速递肝病

精神运动警觉任务:在肝性脑病诊断中的作用及其与驾驶能力的关系

The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
PubMed 文献 · J Hepatol · 2019-01-08

该研究纳入145例肝硬化患者和66名健康志愿者,评估精神运动警觉任务(PVT)在肝性脑病(HE)诊断及驾驶能力评估中的作用。PVT指标与MELD、血氨、PHES和EEG显著相关,PVT、PHES和EEG均预测HE相关住院和/或死亡,但均未预测事故或交通违章。作者认为PVT值得进一步研究用于HE和驾驶能力评估。

要点

  • 肝硬化患者PVT表现较健康志愿者差,PVT指标与MELD、血氨、PHES和EEG显著相关。
  • PVT、PHES和EEG均预测随访期间HE相关住院和/或死亡,但均未预测事故或交通违章。
  • 将因HE相关原因停止驾驶的6例患者建模为后续6个月和12个月内发生事故或罚款后,PVT可预测事故和交通违章。

核心结论

  • PVT值得进一步研究用于HE和驾驶能力评估。
  • 作者建议该测试有助于量化HE和识别肝硬化患者中的危险驾驶者。

研究设计与样本

  • 共145例患者(120例男性,59±10岁,MELD评分13±5)接受PVT;其中117例完成驾驶问卷,106例接受PHES和EEG并据以结合临床评估分为无损伤组(n=51)、轻微型HE组(n=35)和轻度 overt HE组(n=20)。
  • 所有患者平均随访13±5个月,观察事故和/或交通违章、HE相关住院和死亡的发生情况。
  • 66名健康志愿者按性别、年龄和教育程度均衡分布,作为PVT的参考队列。

主要发现

  • 患者PVT表现较健康志愿者差,PVT指标与MELD、血氨水平、PHES和EEG结果显著相关。
  • 神经精神表现/PVT指标与驾照/驾驶状态之间观察到显著关联。
  • PVT、PHES和EEG结果均预测随访期间HE相关住院和/或死亡;均未预测事故或交通违章。
  • PVT上反应时间最慢和失误最多者尽管持有驾照却常常不开车。
  • 将因HE相关原因停止驾驶的6例患者建模为后续6个月和12个月内发生事故或罚款后,即使校正MELD和年龄,PVT仍为事故和交通违章的预测因素。

临床怎么用

  • 作者建议PVT有助于量化HE和识别肝硬化患者中的危险驾驶者,并认为其值得进一步研究用于HE和驾驶能力评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatic encephalopathy (HE) is a syndrome of decreased vigilance and has been associated with impaired driving ability. The aim of this study was to evaluate the psychomotor vigilance task (PVT), which is used to assess both vigilance and driving ability, in a group of patients with cirrhosis and varying degrees of HE. METHODS: A total of 145 patients (120 males, 59 ± 10 years, model for end-stage liver disease [MELD] score 13 ± 5) underwent the PVT; a subgroup of 117 completed a driving questionnaire and a subgroup of 106 underwent the psychometric hepatic encephalopathy score (PHES) and an electroencephalogram (EEG), based on which, plus a clinical evaluation, they were classed as being unimpaired (n = 51), or as having minimal (n = 35), or mild overt HE (n = 20). All patients were followed up for an average of 13 ± 5 months in relation to the occurrence of accidents and/or traffic offences, HE-related hospitalisations and death. Sixty-six healthy volunteers evenly distributed by sex, age and education served as a reference cohort for the PVT. RESULTS: Patients showed worse PVT performance compared with healthy volunteers, and PVT indices significantly correlated with MELD, ammonia levels, PHES and the EEG results. Significant associations were observed between neuropsychiatric performance/PVT indices and licence/driving status. PVT, PHES and EEG results all predicted HE-related hospitalisations and/or death over the follow-up period; none predicted accidents or traffic offences. However, individuals with the slowest reaction times and most lapses on the PVT were often not driving despite having a licence. When patients who had stopped driving for HE-related reasons (n = 6) were modelled as having an accident or fine over the subsequent 6 and 12 months, PVT was a predictor of accidents and traffic offences, even after correction for MELD and age. CONCLUSIONS: The PVT is worthy of further study for the purposes of both HE and driving ability assessment. LAY SUMMARY: Hepatic encephalopathy (HE) is a complication of advanced liver disease that can manifest as excessive sleepiness. Some patients with HE have been shown to have difficulty driving. Herein, we used a test called the Psychomotor Vigilance Task (PVT), which measures sleepiness and can also be used to assess driving competence. We showed that PVT performance is fairly stable in healthy individuals. We also showed that PVT performance parallels performance in tests which are commonly used in cirrhotic patients to measure HE. We suggest that this test is helpful in quantifying HE and identifying dangerous drivers among patients with cirrhosis.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Formentin C, De Rui M, Zoncapè M, et al. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability. J Hepatol. 2019. PMID: 30633946. doi:10.1016/j.jhep.2018.12.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。